Burning Rock and Abbisko Therapeutics Announce Strategic Partnership on Co-development of Companion Diagnostics for ABSK091

Go back to Burning Rock and Abbisko Therapeutics Announce Strategic Partnership on Co-development of Companion Diagnostics for ABSK091
(NASDAQ: BNR) Delayed: 20.41 +0.81 (4.13%)
Previous Close $19.60    52 Week High
Open $19.61    52 Week Low
Day High $20.76    P/E N/A 
Day Low $19.43    EPS
Volume 1,197,846